Kymera Therapeutics (KYMR) Treasury Shares (2019 - 2026)

Kymera Therapeutics (KYMR) has 8 years of Treasury Shares data on file, last reported at $1.5 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 26.88% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 26.88% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 79.45% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.5 million, up from $1.3 million in the prior quarter.
• Over the last five years, Treasury Shares for KYMR reached as high as $1.5 million in Q1 2026 and fell as low as $121504.0 in Q1 2022.
• Historically, Treasury Shares has averaged $746263.2 across 5 years, with a median of $636585.0 in 2024.
• Across the five-year window, Treasury Shares soared 646.7% in 2022 and grew 26.38% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $281843.0 in 2022, then soared by 110.45% to $593140.0 in 2023, then advanced by 26.38% to $749604.0 in 2024, then surged by 79.45% to $1.3 million in 2025, then grew by 14.13% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $1.5 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.